Status:

WITHDRAWN

Effects of Intralipid Versus Olive Oil Infusions on Endothelial Function, Immune Function, Inflammatory Markers

Lead Sponsor:

Emory University

Collaborating Sponsors:

American Diabetes Association

Conditions:

Diabetes

Hypertension

Eligibility:

All Genders

18-65 years

Phase:

PHASE2

PHASE3

Brief Summary

Recent evidence suggests that increased levels of a circulation fat (free fatty acids or FFAs) can cause high blood pressure and cardiac complications. Intralipid is the only type of fat approved by t...

Eligibility Criteria

Inclusion

  • Healthy males or females
  • BMI 25 -35 kg/m2, between the ages of 18 and 65 years
  • BP \< 140/80 mm Hg and no prior history of hypertension

Exclusion

  • Pregnancy or breast feeding
  • History of diabetes, hypertension, fasting triglyceride levels \> 250 mg/dL, liver disease (ALT 2.5x \> upper limit of normal), serum creatinine ≥ 1.5 mg/dL, -Smokers or ex-smoker \< 3 months of cessation, drug or alcohol abuse
  • Mental condition rendering the subject unable to understand the scope and possible consequences of the study

Key Trial Info

Start Date :

November 1 2009

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 1 2011

Estimated Enrollment :

Patients enrolled

Trial Details

Trial ID

NCT00989339

Start Date

November 1 2009

End Date

December 1 2011

Last Update

July 4 2014

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.

Effects of Intralipid Versus Olive Oil Infusions on Endothelial Function, Immune Function, Inflammatory Markers | DecenTrialz